Back to mobile site

Autolus Therapeutics (AUTL) Deal with Blackstone Overall Positive - Mizuho

November 8, 2021 1:03 PM EST Send to a Friend
Mizuho Securities analyst Mara Goldstein reiterated a Buy rating and $18.00 price target on Autolus Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login